Survey on cancer drug survival expectations
Part of Cancer clinical trials.
This study asks people who have or have had cancer to share their thoughts on how much a cancer drug may extend life. It aims to understand patient expectations about survival benefits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You live in the United States.
- You speak English fluently.
- You have been diagnosed with cancer (other than non-melanoma skin cancer) at some point.
- You can complete a survey that takes about 2-3 minutes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to explain the benefits and risks of new cancer drugs in a way that is easier to understand. It helps researchers learn how to communicate better with patients like you.
This study surveys adults with cancer experience about how they value new cancer drugs, helping doctors better communicate treatment options. Your responses could improve how benefits and risks are explained to future patients.
This trial is testing a questionnaire about language used in cancer care. You may be able to help by filling out a survey if you are 18+ and receiving palliative care or ongoing anti-cancer treatment.
This study collects information about how cancer care affects daily life, treatment side effects, and quality of life, and it stores imaging and related data for future research. You might be able to take part if you’re scheduled for treatment at the center (or you’re a healthy volunteer) and can complete the questionnaires.
This survey asks cancer patients, their relatives, and healthcare workers in the UK about how well current cancer care laws work with today's technology. Your feedback helps shape future cancer care policies and practices.
This British Columbia study looks at how well different cancer treatments work in real life when doctors aren't sure which option is best. You and your doctor would choose a treatment, and researchers will track your results to help others.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.